Low human papillomavirus prevalence in head and neck cancer: results from two large case-control studies in high-incidence regions

International Agency for Research on Cancer, Lyon, France.
International Journal of Epidemiology (Impact Factor: 9.2). 03/2011; 40(2):489-502. DOI: 10.1093/ije/dyq249
Source: PubMed

ABSTRACT Recent studies support an important role for human papillomavirus (HPV) in a subgroup of head and neck squamous cell carcinomas (HNSCC). We have evaluated the HPV deoxyribonucleic acid (DNA) prevalence as well as the association between serological response to HPV infection and HNSCC in two distinct populations from Central Europe (CE) and Latin America (LA).
Cases (n = 2214) and controls (n = 3319) were recruited from 1998 to 2003, using a similar protocol including questionnaire and blood sample collection. Tumour DNA from 196 fresh tissue biopsies was analysed for multiple HPV types followed by an HPV type-specific polymerase chain reaction (PCR) protocol towards the E7 gene from HPV 16. Using multiplex serology, serum samples were analysed for antibodies to 17 HPV types. Statistical analysis included the estimation of adjusted odds ratios (ORs) and the respective 95% confidence intervals (CIs).
HPV16 E7 DNA prevalence among cases was 3.1% (6/196), including 4.4% in the oropharynx (3/68), 3.8% in the hypopharynx/larynx (3/78) and 0% among 50 cases of oral cavity carcinomas. Positivity for both HPV16 E6 and E7 antibodies was associated with a very high risk of oropharyngeal cancer (OR = 179, 95% CI 35.8-899) and hypopharyngeal/laryngeal cancer (OR = 14.9, 95% CI 2.92-76.1).
A very low prevalence of HPV DNA and serum antibodies was observed among cases in both CE and LA. The proportion of head and neck cancer caused by HPV may vary substantially between different geographical regions and studies that are designed to evaluate the impact of HPV vaccination on HNSCC need to consider this heterogeneity.

Download full-text


Available from: José Eluf-Neto, Jun 28, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Overall, head and neck sqamous cell carcinoma accounts for more than 550,000 cases annually worldwide. It is well known that human papillomavirus (HPV) is the main risk factor for cervical cancer development. As the incidence and the mortality of cervical cancer are closely related to the HPV prevalence, we hypothesized that there is the same association between HPV prevalence and head and neck squamous cell carcinoma. Therefore we performed the study aiming to compare the level of HPV infection and HPV type distribution between two groups of Lithuanian and Belarusian patients with head and neck sqamous cell carcinoma. One hundred ninety head and neck sqamous cell carcinoma patients were included in the study, 75 from Lithuania and 115 from Belarus. PCR was used for HPV detection and typing. The distribution of HPV infection among head and neck sqamous cell carcinoma patients was similar in the Lithuanian (20.0%) and Belarusian (18.3%) patient groups, however differences were found in the distribution of HPV types. J. Med. Virol. © 2013 Wiley Periodicals, Inc.
    Journal of Medical Virology 03/2014; 86(3). DOI:10.1002/jmv.23750 · 2.22 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: To determine the prevalence of HPV seropositivity among oral squamous cell carcinoma (OSCC) patients and healthy individuals and to correlate the association between HPV 16 seropositivity and risk of OSCC. HPV 16 E6 and E7 plasmids were constructed for the production of recombinant protein which was used as the antigen in ELISA assay. HPV ELISA was performed on serum samples from 50 healthy individuals and 50 OSCC patients. Using the HPV ELISA, 30% (OR=2.25, 95% CI=0.85-5.93) and 18% (OR=1.61, 95% CI=0.53-4.92) of oral cancer patients were found to be HPV 16 E6 and E7 seropositive respectively. Significant association was found between HPV 16 seropositivity and elevated risk of OSCC in men but not in women subjects. A similar trend was observed in non-betel quid chewers. Potential associations between HPV 16 E6/E7 seropositivity and oral cancer were revealed in men and non-betel quid chewers subjects suggesting a possible etiological role of HPV 16 in subgroup of OSCC patients in Malaysia. This article is protected by copyright. All rights reserved.
    Oral Diseases 12/2013; 20(8). DOI:10.1111/odi.12218 · 2.40 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: OBJECTIVE: Studies reporting low prevalence of HPV in OSCC with declining age at presentation are increasing. The aim of this study was to determine the prevalence of HPV in a group of OSCC cases and controls in a Mexican population. METHODS: The matched case-control study included 80 OSCC cases and 320 controls. HPV/DNA presence was evaluated through PCR amplification using three sets of consensus primers for the L1 gene. A conditional logistic regression analysis was carried out for the matched OSCC cases and controls. Interactions between risk factors and OCSS were tested in the construction process of the models. RESULTS: HPV prevalence was 5% in OSCC cases and 2.5% in controls. HPV-detected types were 16, 18 and 56. According to conditional logistics regression model, an association was detected between HR-HPV and OSCC. All HR-HPV-positive OSCC cases corresponded to young patients (<45 years), non-smokers and non-alcohol drinkers. CONCLUSIONS: The HR-HPV can be a contributing factor to oral carcinogenesis, especially in younger individuals without known risk factors such as tobacco and alcohol.
    Oral Diseases 01/2013; 19(8). DOI:10.1111/odi.12071 · 2.40 Impact Factor